Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.

Guglielmo, R., Martinotti, G., Janiri, L., Gabapentin as add-on treatment for somatoform disorder: a case report, <<CLINICAL NEUROPHARMACOLOGY>>, 2012; 35 (1): 45-46. [doi:10.1097/WNF.0b013e31823e669b] [http://hdl.handle.net/10807/8736]

Gabapentin as add-on treatment for somatoform disorder: a case report

Guglielmo, Riccardo;Martinotti, Giovanni;Janiri, Luigi
2012

Abstract

Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.
Inglese
Guglielmo, R., Martinotti, G., Janiri, L., Gabapentin as add-on treatment for somatoform disorder: a case report, <<CLINICAL NEUROPHARMACOLOGY>>, 2012; 35 (1): 45-46. [doi:10.1097/WNF.0b013e31823e669b] [http://hdl.handle.net/10807/8736]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/8736
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact